MEGEETRON 160MG TAB

About

MEGEETRON 160 MG TAB. is a synthetic progestin, primarily used for its appetite-stimulating and antineoplastic properties. As a derivative of progesterone, it exerts its effects by modulating hormonal pathways and influencing metabolic processes. In oncology, it is utilized in the palliative treatment of advanced breast and endometrial cancers, where it can help to control tumor growth and alleviate symptoms. Its mechanism in cancer involves anti-estrogenic effects and direct cytotoxic actions on certain cancer cells.

Beyond its role in cancer, MEGEETRON is widely recognized for its ability to stimulate appetite and promote weight gain in patients experiencing cachexia or significant weight loss due to chronic illness, such as AIDS or advanced cancer. This effect is thought to be mediated through its influence on cytokine production and hypothalamic appetite regulation. The 160 mg dosage is a common strength for both its antineoplastic and appetite-stimulating indications, requiring careful consideration of patient-specific factors and potential side effects.

Uses

• Palliative treatment of advanced breast cancer.
• Management of advanced endometrial cancer.
• Appetite stimulation in AIDS-related cachexia.
• Treatment of significant weight loss in cancer patients.

Directions For Use

Take orally with or without food, as directed by a physician. Dosage and duration depend on the specific indication and patient response.

Benefits

• Can slow progression of certain cancers.
• Effective in stimulating appetite.
• Promotes weight gain in cachectic patients.
• Improves quality of life in advanced illness.
• Oral administration for convenience.
• Reduces symptoms associated with advanced cancer.

Side Effects

• Weight gain
• Nausea
• Vomiting
• Diarrhea
• Flatulence
• Breakthrough bleeding
• Thromboembolic events (e.g., DVT, PE)
• Adrenal suppression
• Hot flashes
• Headache
• Insomnia
• Rash

Safety Measures

• Alcohol - No specific contraindication, but excessive alcohol consumption may exacerbate gastrointestinal side effects or liver strain.
• Pregnancy - Contraindicated during pregnancy due to potential harm to the fetus, including feminization of male fetuses.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and potentially affect the infant or suppress lactation.
• Liver - Use with caution in patients with liver impairment; monitor liver function tests regularly.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary.
• Lung - Monitor for signs of thromboembolic events, such as pulmonary embolism, especially in patients with pre-existing risk factors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.